North Dakotan leads while living with HIV, earns Bush Fellowship
A Bismarck man who has experienced substance abuse, recovery and living with HIV is hoping to develop his leadership skills after being awarded a Bush Foundation fellowship.
'I've been able to change my own life and work to help others to do the same,' Jason Grueneich told the North Dakota Monitor. 'I'm just lucky to be alive and here doing the work. And it's amazing that the Bush Foundation saw something in me.'
Grueneich's work includes being an advocate for those living with HIV. He created Bismarck's first LGBTQ+ recovery group and this year founded Shine Bright and Live, an HIV-focused nonprofit, and helped repeal a North Dakota state law that he said stigmatized people who are HIV positive.
Grueneich is one of three North Dakotans awarded a Bush Fellowship in 2025. Up to 30 Bush Fellows are selected each year to receive up to $150,000 to support their leadership goals. Fellows can come from any sector — including business, nonprofit and government, according to the Bush Foundation.
Grueneich said the Bush Foundation isn't so much about funding a project but investing in leaders.
'Leaders work to bring as many people with them as possible,' Grueneich said. 'It ripples out into the community and raises people up.'
Gruenich grew up in Bismarck but said he moved away, developed a substance abuse problem and became infected with HIV, the virus that causes AIDS.
He returned to Bismarck and went through a recovery program in 2016.
Since then, 'I have dedicated myself to community,' Grueneich said.
Two other North Dakota also were awarded a Bush Fellowship.
Sarah Dixon-Hackey of West Fargo will pursue certification in suicide prevention skills, expand her expertise in digital media, and deepen her research into cultural disparities in care, according to a news release. She has created storytelling projects with college students and produced podcasts for refugee families to amplify underrepresented voices, especially on the topic of mental health.
Richard Pallay III of Fargo has used his experience as a DJ to found the cultural initiative WEAREONE. He also launched Soul Dads, a peer support network for Black fathers that blends mentorship with creative expression. Pallay will use his Bush Fellowship to launch a statewide artist network and scale Soul Dads into a model that can be replicated, the news release said.
Grueneich chairs the North Dakota HIV Advisory Board while working in state government. He has worked for the Department of Transportation for the past five years and is operations manager for the driver's license division.
After founding Shine Bright and Live in January, Grueneich spent time at the Capitol advocating for the repeal of a state law that makes it a felony to willfully transfer body fluid containing the HIV virus.
Rep. Gretchen Dobervich, D-Fargo, sponsored House Bill 1217 that repeals the law.
She said the law singled out HIV from other infectious diseases by creating the felony crime and discouraged people from getting tested for HIV, leading to the potential spread of the virus.
The law, 'had the opposite effect of what it was intended,' Dobervich said.
She said Grueneich was instrumental in getting the bill through the Legislature.
'He was able to make the issue real,' Dobervich said.
Testifying in front of a legislative committee was new for him, Grueneich said.
'A leader faces fears,' Grueneich said. 'Somebody living with HIV, standing in front of the Legislature numerous times when there's a lot of stigma about HIV can be daunting.'
In his testimony, Gruenich cited President Donald Trump, who in his first term in 2019, used the State of the Union address to announce a plan to end the HIV epidemic.
Grueneich said it was a way to find common ground on HIV issues.
'Unfortunately, we see now the administration is cutting funding for HIV prevention. It's cutting funding for the years of work we've had on finding HIV vaccination or care,' he said.
Grueneich said one way he hopes to benefit from the Bush Fellowship is learning how to deal with traumatic life experiences that come with working with high-risk communities such as HIV and recovery.
'You're continually working through trauma and loss,' Grueneich said. 'I want to learn how to heal and process those losses, so I can teach others how they can process that and then refill their cups so they can keep doing the work that's necessary.'
Editor's note: The North Dakota Monitor is a recipient of funding from the Bush Foundation through its media partnership program.
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
SUPPORT: YOU MAKE OUR WORK POSSIBLE
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
4 hours ago
- Medscape
Fast Five Quiz: Sjögren Disease Differential Diagnoses
Learn more about oral dryness in Sjögren disease. Dry eye, or xerophthalmia, is another other classic symptom of Sjögren disease. Similarly, several factors can also cause dry eye, which must be ruled out for accurate diagnosis. For example, data indicate that androgen can significantly influence the lacrimal gland/tear production and overall optical health. Hypoandrogenemia is a known cause of dry eye along with Vitamin A deficiency; hyperandrogenemia is another known cause of dry eye, especially in females and those with polycystic ovary syndrome. Hypercalcemia, anemia, and Vitamin B deficiency are usually associated with dry mouth, rather than dry eye. Elevated CRP does not appear to be specifically associated with dry eye, and levels are usually normal in Sjogren disease. Learn more about dry eye in Sjögren disease. According to the most recent ACR classification guidelines, dry eyes and/or mouth must persist for more than 3 months after controlling for differential diagnoses. Their criteria suggest Sjögren disease can be confirmed by a classification score of at least 4 points from factors such as histology of the labial salivary gland (up to 3 points), detection of SS-A/Ro antibodies (3 points), pathological Schirmer test (1 point), whole saliva flow rate ≤ 0.1ml/min (1 point), and abnormal ocular staining score (1 point). Although various diseases can cause chronic dry eye, external factors such as drug use and environmental factors can be excluded upon resolution when the patient is removed from exposure. Learn more about classification criteria for Sjögren disease. Experts note that Sjogren disease is typically diagnosed based on 'the patient's subjective sicca symptoms if these cannot be explained by other differential diagnoses, after excluding certain diseases and using the objective classification criteria.' Graft versus host disease, along with amyloidosis, sarcoidosis, HIV, HCV, and history of head and neck radiation therapy, is specifically recommended by the ACR classification system to be excluded when diagnosing Sjögren disease. Further, pre‐existing lymphoma is no longer part of this exclusion criteria. Although fatigue is common in both Sjogren disease and fibromyalgia, presentation of subjective sicca usually prompts the differential diagnosis for Sjögren disease in the ACR classification. Chronic pancreatitis and rheumatic fever are also not typically associated with sicca symptoms. Learn more about differential diagnosis for Sjögren disease. Contrast is a rare but often overlooked cause of salivary gland enlargement, another characteristic Sjogren disease symptom. It is most often associated with iodine contrast media, leading to its nickname of 'Iodide mumps.' Other potential causes of salivary gland enlargement include several types of infections and inflammatory conditions, neoplasms, and immunosuppression. Though parotid enlargement can occur with gadolinium use, the association is not as frequent as iodine. Barium and microbubble use have not been consistently shown to directly cause parotid enlargement. Learn more about parotid gland enlargement in Sjögren disease. Editor's Note: This article was created using several editorial tools, including generative AI models, as part of the process. Human review and editing of this content were performed prior to publication. Lead image: Peakstock/Science Source
CNBC
6 hours ago
- CNBC
$9.7 million of U.S.-funded contraceptives for poor nations to be burned in France: Reuters
U.S.-funded contraceptives worth nearly $10 million are being sent to France from Belgium to be incinerated, after Washington rejected offers from the United Nations and family planning organizations to buy or ship the supplies to poor nations, two sources told Reuters. A spokesperson for the U.S. State Department confirmed to Reuters on Wednesday that a decision had been taken to destroy the stock. The supplies have been stuck for months in a warehouse in Geel, a city in the Belgian province of Antwerp, following President Donald Trump's decision to freeze U.S. foreign aid in January. They comprise contraceptive implants and pills as well as intrauterine devices to help prevent unwanted pregnancies, according to seven sources and a screengrab shared by an eighth source confirming the planned destruction. The U.S. government will spend $167,000 to incinerate the stocks at a facility in France that handles medical waste, the U.S. State Department confirmed. The spokesperson said that a preliminary decision had been made to destroy certain products from terminated U.S. Agency for International Development contracts. "Only a limited number of commodities have been approved for disposal," the spokesperson said via email, adding that no condoms or HIV medications would be destroyed. U.S. lawmakers have introduced two bills this month to prevent the destruction of the supplies following Trump's decision to shut down USAID, but aid groups say the bills are unlikely to be passed in time to stop the incineration. The Belgian foreign ministry said Brussels had held talks with U.S. authorities and "explored all possible options to prevent the destruction, including temporary relocation." "Despite these efforts, and with full respect for our partners, no viable alternative could be secured. Nevertheless, Belgium continues to actively seek solutions to avoid this regrettable outcome," it said in a statement shared with Reuters on Tuesday. "Sexual and reproductive health must not be subject to ideological constraints," it added. The supplies, worth $9.7 million, are due to expire between April 2027 and September 2031, according to an internal document listing the warehouse stocks and verified by three sources. Sarah Shaw, Associate Director of Advocacy at MSI Reproductive Choices, told Reuters the non-profit organization had volunteered to pay for the supplies to be repackaged without USAID branding and shipped to countries in need, but the offer was declined by the U.S. government. "MSI offered to pay for repackaging, shipping and import duties but they were not open to that... We were told that the U.S. government would only sell the supplies at the full market value," said Shaw. She did not elaborate on how much the NGO was prepared to pay, but said she felt the rejection was based on the Trump's administration's more restrictive stance on abortion and family planning. "This is clearly not about saving money. It feels more like an ideological assault on reproductive rights, and one that is already harming women." She added that many countries in sub-Saharan Africa had relied on USAID for access to contraception and that the aid cuts would lead to a rise in unsafe abortions. The United Nations' sexual and reproductive health agency, UNFPA, also offered to buy the contraceptives outright, three sources told Reuters, without disclosing the financial terms of the proposal. However, negotiations broke down, a source with knowledge of the talks said, in part due to a lack of response from the U.S. government. UNFPA declined to comment. One of the sources with knowledge of the issue said that the Trump administration was acting in accordance with the Mexico City policy, an anti-abortion pact in which Trump reinstated U.S. participation in January. The pact forbids the U.S. government from contributing to or working with organizations providing funding or supplies that offer access to abortions. The source said there was no way for the U.S. government to ensure that UNFPA would not share the contraceptives with groups offering abortions, violating the Mexico City policy. The State Department also told Reuters these were factors in their decision on Wednesday, and added that it had avoided $34.1 million in costs by cancelling other orders placed under the Biden administration. The source also said the matter was complicated by the fact that the contraceptives in Belgium were embossed with the USAID trademark and Washington did not want any USAID-branded supplies to be rerouted elsewhere. UNFPA did not immediately respond to requests for comment on the concerns raised by the source. One of the two sources who told Reuters the stocks of contraceptives were being trucked to France said it would likely take dozens of truckloads and at least two weeks to move the supplies out of the Geel warehouse, with a third source also confirming the scale of the operation. The French government did not immediately respond to requests for comment. Chemonics, the contractor managing the supply chain for USAID's family planning program, declined to comment on the plans to destroy the supplies.
Yahoo
7 hours ago
- Yahoo
UNH Stock Falls as UnitedHealth Confirms DOJ Probe. How Should You Play Shares Here?
UnitedHealth (UNH) shares inched down on Thursday after the insurance giant confirmed the U.S. Justice Department is investigating its Medicare billing practices. The DOJ is investigating whether the NYSE-listed firm artificially inflated Medicare reimbursements by overstating or exaggerating patient health conditions. More News from Barchart NVDA Broken Wing Butterfly Trade Targets A Profit Zone Between 150 and 160 Is Opendoor Stock a Buy at New 52-Week Highs? Can Lucid Motors Stock Hit $7 in 2025? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Including today's decline, UnitedHealth stock is down more than 50% versus its year-to-date high. Medicare Advantage Matters a Lot for UNH Shares The DOJ's probe adds to a long list of headwinds that have plagued UNH shares this year, including rising medical costs and unexpected management shakeup. An investigation into the Medicare-focused business is significant for investors as it accounted for nearly one-third of the company's overall revenue in 2024. The investigation could result in fines, further damage to the insurer's reputation, or even revised reimbursement policies, potentially leading to added pressure on UnitedHealth stock. If the company is indeed found guilty of fraud in Medicare billing practices, it could shatter investor sentiment and trigger a further decline in its share price in the second half of 2025. Is it Time to Sell UnitedHealth Stock Now? According to Jared Holz, a Mizuho strategist, the DOJ investigation may not be an adequate reason to sell UnitedHealth shares since the possibility of a probe was well-telegraphed and didn't really come as a shock for investors. The investment firm maintains its 'Buy' rating on the world's largest health insurance firm with a $350 price target indicating potential upside of nearly 25% from here. A historically low valuation and the management's expectations that earnings will still grow in fiscal 2026 were cited as reasons for the bullish call on UNH stock in Mizuho's latest research note to clients. What's also worth mentioning is that UnitedHealth insiders have actually been aggressive buyers of the healthcare stock through its ongoing turmoil in 2025. UnitedHealth Remains a Wall Street Favorite While things haven't been pleasant for UnitedHealth stock for quite some time, it still hasn't fallen out of favor with Wall Street analysts. The consensus rating on UNH shares remains at 'Moderate Buy' with the mean target of roughly $357 indicating potential upside of more than 25% from current levels. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
